BioGaia signs exclusive distribution agreement with Recordati in Spain and Portugal
This partnership leverages the Iberian market's growing demand for scientifically backed health products, expanding access to the company's probiotic portfolio.
See the latest news and media coverage for BioGaia. We track all announcements, press releases, and industry mentions in real time, all in one place.
Swedish probiotic health products company
biogaiagroup.comLast updated
In short: BioGaia achieved strong sales growth in 2026, expanded its distribution networks, and acquired full ownership of its U.S. distributor.
This partnership leverages the Iberian market's growing demand for scientifically backed health products, expanding access to the company's probiotic portfolio.
Operating profit increased 22% to SEK 132.1 million and adjusted operating margin reached 33%.
She was elected at the Annual General Meeting in May and brings experience from Novonesis and DuPont Nutrition & Biosciences.
Shareholders approve financial statements, SEK 4.00 per share dividend, board elections, and Performance Share Program 2026/2029.
BioGaia (BIOG-B.ST) signed a long-term agreement with the Italian pharmaceutical company Recordati (REC.MI) for the distribution of its products in Spain and Portugal.According to a...
Worldquant has taken a public short position in the biotechnology company Biogaia. This position amounts to 0.5% of the share capital, compared to less...
The Swedish health company BioGaia has significantly increased revenue and profit in the second quarter of 2026. Particularly ...
Worldquant has become a newly declared short seller within the probiotics company Biogaia, after having raised its short position to 0.50...
Track BioGaia and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to BioGaia and other trending companies.